Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Roche”
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
United States, Argentina, Australia, Belgium, Brazil +13 more
- Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Diabetic Macular Edema · Neovascular Age-related Macular Degeneration · Retinal Vein Occlusion
China
Sponsor: Hoffmann-La Roche
Moderately to Severely Active Crohns Disease
United States, Australia, Brazil, Mexico, Taiwan +2 more
- An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care TreatmentActive Not Recruiting
Sponsor: Hoffmann-La Roche
Von Willebrand Disease, Type 3
United States, Belgium, Canada, Colombia, France +9 more
Sponsor: Hoffmann-La Roche
Cancer
Belgium, Canada, China, Costa Rica, France +9 more
Sponsor: Hoffmann-La Roche
Von Willebrand Disease, Type 3
United States, Belgium, Canada, Colombia, France +9 more
Sponsor: Hoffmann-La Roche
Non-small Cell Lung Cancer
United States
Sponsor: Hoffmann-La Roche
Healthy Participants
China
- A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaActive Not Recruiting
Sponsor: Hoffmann-La Roche
Lymphoma
United States, Puerto Rico
Sponsor: Treos Bio Limited
Colorectal Cancer Metastatic
United States
Sponsor: University Hospital, Clermont-Ferrand
HIV Infections
France, Guadeloupe, Reunion
- A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or OverweightNot Yet Recruiting
Sponsor: Hoffmann-La Roche
Obesity or Overweight
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer · KRAS G12C Lung Cancer
United States, Argentina, Australia, Belgium, Brazil +23 more
Sponsor: Hoffmann-La Roche
Parkinson's Disease
United States, Australia, Austria, Brazil, Canada +12 more
Sponsor: Hoffmann-La Roche
Multiple Myeloma
China
Sponsor: Hoffmann-La Roche
Hemophilia A
United States, Germany, Hungary, Italy, Japan +5 more
- A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Muscle-invasive Urothelial Carcinoma
United States, Argentina, Australia, Canada, Denmark +10 more
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States, Argentina, Brazil, Canada, China +8 more
- A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Brazil, France, Germany +4 more
Sponsor: Hoffmann-La Roche
Hemophilia A
United States, Belgium, China, France, Germany +10 more
- A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple MyelomaActive Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Myeloma
United States, Australia, Belgium, France, Germany +3 more
Sponsor: Hoffmann-La Roche
Breast Cancer
Belgium, Denmark, Finland, Germany, Italy +3 more
- To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast CancerRecruiting
Sponsor: Hoffmann-La Roche
Breast Cancer
United States, Argentina, Australia, Belgium, Mexico +3 more
Sponsor: Hoffmann-La Roche
Atopic Dermatitis
United States, Brazil, Canada, Germany, Italy +2 more
Sponsor: Hoffmann-La Roche
Diffuse Large B-Cell Lymphoma
China, Hong Kong